Our Newsroom
This is the place to get the latest exciting news about Route 92 medical.
Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study
Data from 250-patient, 31-center, randomized controlled trial presented at European Stroke Organisation Conference Three highest enrolling sites reported 96% delivery of the super-bore HiPoint 88 Reperfusion System to MI occlusions and 84% first pass effect HiPoint 88 Reperfusion System secures 510(k) clearance becoming the first stroke treatment system to achieve super-bore direct aspiration label SAN […]
View More
Route 92 Medical Announces Settlement of Patent Litigation with Q’Apel Medical
View More
Route 92 Medical Receives Australian Therapeutic Goods Administration Approval for itsPortfolio of Neurovascular Interventional Products for Treating Patients with Acute Ischemic Stroke
View More
First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat IdiopathicIntracranial Hypertension
View More